Garmin enters mid-range wearable market with subscription-free Cirqa tracker
The Cirqa offers up to 10 days of battery life and advanced health monitoring without the mandatory subscriptions required by competitors like Whoop, positioning itself between Google’s Fitbit Air and premium wellness trackers.
Garmin has launched the Cirqa, a new screen-free fitness tracker priced at $199.99, marking a strategic entry into the mid-range wearable segment. The device is designed to eliminate visual distractions by forgoing a display, instead relying on an adjustable fabric strap that can be worn on the wrist or as an armband. Garmin states that this design choice supports up to 10 days of battery life between charges, a significant duration for a device offering continuous health monitoring.
The Cirqa utilises a suite of sensors to track heart rate, blood oxygen saturation, skin temperature, and motion data. This hardware allows the device to monitor activities around the clock and provide detailed insights via the Garmin Connect app. Users can select from more than 80 activities, such as running or yoga, either through the app or by using a single side button as a shortcut. The system also evaluates training effectiveness and recovery status, advising users on whether their body is ready for the next session or requires rest.
In terms of pricing and business model, the Cirqa positions itself distinctly against key competitors. Google’s Fitbit Air is available for $99 upfront, though advanced features require an optional $99/year Google Health Premium subscription. Conversely, Whoop’s hardware is exclusively available through subscriptions starting at $199/year. The Cirqa’s $199.99 upfront cost sits between these two models, offering comprehensive health data without a mandatory recurring fee.
The device provides granular sleep analysis, breaking down sleep stages, breathing patterns, and heart rate to generate a nightly sleep score. For menstrual health, the Cirqa uses skin temperature monitoring to offer period predictions and past ovulation estimates. Garmin also notes that continuous monitoring of heart rate and blood oxygen can assist in detecting potential conditions such as asthma and sleep apnea, although the source material does not provide clinical validation data for these specific detections.
The Cirqa is available now through Garmin’s online store. By combining a higher upfront cost than entry-level trackers with a no-subscription model, Garmin aims to capture consumers who desire advanced wellness metrics without the long-term financial commitment associated with subscription-based wearable ecosystems.
